Diels–Alder Reaction of 1,3-Diarylbenzo[<i>c</i>]furans with Thiophene <i>S,S</i>-Dioxide/Indenone Derivatives: A Facile Preparation of Substituted Dibenzothiophene <i>S,S</i>-Dioxides and Fluorenones
作者:Meganathan Nandakumar、Jayachandran Karunakaran、Arasambattu K. Mohanakrishnan
DOI:10.1021/ol501175q
日期:2014.6.6
One pot syntheses of substituted dibenzothiophene S,S-dioxides and fluorenones were successfully achieved by Diels–Alder reaction of benzo[c]furans with thiophene S,S-dioxides and indenones, respectively. Photophysical properties of representative seven- and nine-membered dibenzothiophene S,S-dioxide acenes were also reported.
通过苯并[ c ]呋喃的狄尔斯-阿尔德反应分别与噻吩S,S-二氧化物和茚满酮进行Diels-Alder反应,成功地完成了一锅合成取代的二苯并噻吩S,S-二氧化物和芴酮的反应。还报道了代表性的七元和九元二苯并噻吩S,S-二氧化物并苯的光物理性质。
Sample plate
申请人:BP OIL INTERNATIONAL LIMITED
公开号:EP2008716A1
公开(公告)日:2008-12-31
A sample plate, and portable apparatus comprising a sample plate and a base portion, which sample plate comprises a sample inlet, a reaction zone, an analysis zone, and at least one separation zone, the sample plate being adapted to allow;
(a) a sample fluid to be fed to the sample plate through the inlet to the reaction zone or optionally to a separation zone, which separation zone separates the sample fluid into two or more fractions at least one of which is fed to the reaction zone;
(b) a reactant to be fed to the reaction zone;
(c) the reaction zone to be maintained under conditions that enable reaction to occur between the reactant and the sample fluid or fraction thereof to produce a product fluid; and
(d) transfer of the product fluid to the analysis zone or optionally to a separation zone in which the product fluid is separated into two or more fractions, at least one of which is transferred to the analysis zone.
A sample plate, portable analysis apparatus and method of analysing sulphur and/or nitrogen compounds in a sample fluid, the method comprising feeding a sample fluid to a sample plate having a sample inlet, a reaction zone, an analysis zone, and at least one separation zone, the sample plate being adapted to allow; (a) a sample fluid to be fed to the sample plate through the inlet to the reaction zone or optionally to a separation zone, which separation zone separates the sample fluid into two or more fractions at least one of which is fed to the reaction zone; (b) a reactant to be fed to the reaction zone; (c) the reaction zone to be maintained under conditions that enable reaction to occur between the reactant and the sample fluid or fraction thereof to produce a product fluid; and (d) transfer of the product fluid to the analysis zone or optionally to a separation zone in which the product fluid is separated into two or more fractions, at least one of which is transferred to the analysis zone.
PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO
申请人:VERA THERAPEUTICS, INC.
公开号:US20210171437A1
公开(公告)日:2021-06-10
The present disclosure pertains to peptide nucleic acid (PNA) monomers and oligomers, as well as methods and compositions useful for the preparation of PNA monomer precursors (e.g. PNA Monomer Esters, Backbone Esters and Backbone Ester Acid Salts, as described below) that can be used to prepare PNA monomers wherein said PNA monomers can be used to prepare said PNA oligomers. In some embodiments, the disclosure features sulfonic acid salts of Backbone Ester compounds, which sulfonic acid salts generally tend to be crystalline and can be obtained in reasonably good yield, often without requiring any chromatographic purification of the reaction product of the Backbone Ester synthesis reaction. This disclosure also pertains to novel methods for the synthesis of said Backbone Ester compounds and novel methods for the formation of the related sulfonic acid salts. Exemplary ester groups include, but are not limited to, 2,2,2-trichloroethy-(TCE), 2,2,2-tribromoethyl-(TBE), 2-iodoethyl-groups (2-IE) and 2-bromoethyl-(2-BrE) as the ester group. These particular ester groups can be removed under conditions where both Boc and Fmoc protected amine groups are stable.
PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY
申请人:VERA THERAPEUTICS, INC.
公开号:US20210206809A1
公开(公告)日:2021-07-08
This application pertains to orthogonally protected esters of peptide nucleic acid (PNA) monomers, which ester groups can be removed under conditions that permit typical backbone and side chain acid- and base-labile protecting groups to remain substantially intact thereby permitting the high yield of PNA monomer carboxylic acids that are suitable for use in PNA oligomer synthesis. Exemplary ester groups include, but are not limited to, 2,2,2-trichloroethyl (TCE), 2,2,2-tribromoethyl (TBE), 2-bromoethyl (2-BE) and 2-iodoethyl groups (2-IE). This invention also pertains to novel methods for the synthesis of Backbone Ester compounds and related Backbone Ester Acid Salts.